Specific solvents may increase risk of Parkinson's disease

June 27, 2012
Specific solvents may increase risk of parkinson's disease
Exposure to specific solvents is associated with an increased risk of Parkinson's disease, according to a study published in the June issue of the Annals of Neurology.

(HealthDay) -- Exposure to specific solvents is associated with an increased risk of Parkinson's disease, according to a study published in the June issue of the Annals of Neurology.

In effort to assess whether exposure to specific solvents is associated with Parkinson's disease risk, Samuel M. Goldman, M.D., M.P.H., of The Parkinson's Institute in Sunnyvale, Calif., and colleagues conducted a discordant twin pair design study involving 99 . Participants were interviewed using detailed job task-specific questionnaires regarding lifetime occupations and hobbies.

The researchers found that exposure to trichloroethylene (TCE) correlated with a significantly increased risk of Parkinson's disease (odds ratio [OR], 6.1; P = 0.034). There was a trend toward significance for exposure to perchloroethylene (PERC; OR, 10.5; P = 0.053) and (CCl4; OR, 2.3; P = 0.088).

"Although the present work focused on , solvents are ubiquitous in the environment, and this is particularly true for those implicated in this study -- TCE, PERC, and CCl4," the authors write. "Our findings require replication in other populations with well-characterized exposures, but the potential public health implications are considerable."

Several authors disclosed financial ties to the pharmaceutical, medical device, and health care industries.

Explore further: Twin study finds occupational chemical exposure may be linked to Parkinson's risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Immobility may be key to predicting Parkinson's decline

July 18, 2016

West Australian researchers have found physical symptoms such as having difficulty moving or maintaining one's balance could be the key to predicting cognitive changes in people who suffer from a Parkinson's disease subtype.

Parkinson's disease biomarker found in patient urine samples

July 5, 2016

For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson's disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.